Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-087227
Filing Date
2025-09-12
Accepted
2025-09-12 16:15:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 5957
  Complete submission text file 0001213900-25-087227.txt   8044
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filed by) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SCHEDULE 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 COMMERCE DRIVE FIRST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6677
CITIUS ONCOLOGY, INC. (Subject) CIK: 0001851484 (see all company filings)

EIN.: 994362660 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93794 | Film No.: 251311664
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)